Critical Updates: Field Safety Notices Issued for Medical Devices (Nov 17–21, 2025)
New updates on medical device safety concern all clinical, quality, and regulatory professionals. Between November 17 and November 21, 2025, […]
New updates on medical device safety concern all clinical, quality, and regulatory professionals. Between November 17 and November 21, 2025, […]
On November 25, 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) issued a Class 4 Medicines Defect Notification regarding
The FDA has issued an Early Alert regarding a potential high-risk issue with certain Fresenius Kabi Ivenix Large Volume Pump
Max Mobility/Permobil has initiated an urgent recall of SpeedControl Dials used in their SmartDrive MX2+ Power Assist Devices. This action
Swissmedic, Switzerland’s key regulatory authority for therapeutic products, has outlined measures to strengthen its financial position. The announcement made 25
Supreme Deli LLC, conducting business as Supreme Service Solutions, has announced a voluntary recall of specific Boar’s Head Pecorino Romano
The U.S. Food and Drug Administration (FDA) has officially approved Itvisma (onasemnogene abeparvovec-brve), a gene therapy developed for patients with
NYU Langone Health, in partnership with the National Heart, Lung, and Blood Institute (NHLBI), has announced the development of a
A groundbreaking clinical trial is set to investigate the comparative effects of Transcutaneous Electrical Nerve Stimulation (TENS) and Percutaneous Electrical
The University of Minnesota is advancing research into persistent cognitive issues following mild traumatic brain injuries (mTBIs). A new clinical